Samla, Samer E.
HRN: 21-27-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2022
CEFTRIAXONE 1G (VIAL)
04/16/2022
04/23/2022
IV
2G
OD
Avulsed Wound Contaminated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes